Latest Regulatory News

Pengana Private Equity Trust has updated the Dividend Reinvestment Plan (DRP) price for its upcoming ordinary distribution, maintaining a steady payout of AUD 0.03176 per unit for the half-year ending December 2024.

Clarity Pharmaceuticals has secured a second FDA Fast Track Designation for its 64Cu-SAR-bisPSMA diagnostic agent, aiming to revolutionize prostate cancer imaging and speed regulatory approval.

Amcor plc has taken a pivotal step in its proposed merger with Berry Global by filing the definitive joint proxy statement with the SEC, setting the stage for shareholder votes in February. Integration planning is well underway as both companies prepare to unite their packaging expertise.

Respiri Limited reports a standout December quarter marked by a 67% surge in patient program enrolments and robust revenue growth, bolstered by strategic acquisition synergies from Orb Health. The company is poised for further expansion in 2025 amid promising contract negotiations and evolving US healthcare reimbursement policies.

Poseidon Nickel has taken a strategic leap with a proposed merger with Horizon Minerals, aiming to combine resources and processing infrastructure. Concurrently, exploration programs at Black Swan and Lake Johnston have unveiled significant gold and lithium anomalies, underscoring the potential of the combined entity.

Atrum Coal announces the lifting of suspensions on its Alberta coal mining approvals following a new Ministerial Order, while its legal challenge over previous restrictions advances to trial.

Amcor plc and Berry Global Group, Inc. have entered into a definitive all-stock merger agreement, positioning the combined entity as a global leader in consumer and healthcare packaging with expected annual synergies of $650 million.

Conrad Asia Energy reports solid progress in Q4 2024 with finalized gas sales agreements and promising LNG studies, despite delayed final investment decisions due to regulatory approvals.

Amcor plc and Berry Global Group have filed their definitive joint proxy statement with the SEC, marking a key milestone in their planned all-stock merger. Shareholder meetings are scheduled for February 25, 2025, as the companies aim to create a global packaging powerhouse.

WA Resources Ltd reports significant progress in its West Arunta Project, delivering promising drilling results and metallurgical testwork that pave the way for an updated Mineral Resource estimate in 2025.

Matsa Resources has announced a maiden gold reserve of 46,000 ounces at its Devon Pit Gold Mine, supported by a robust pre-feasibility study and all necessary permits, positioning the company for near-term production.

SomnoMed Limited reported a solid cash flow performance for Q4 2024, with operating activities generating a net inflow of $1.525 million and ending the quarter with $18.5 million in cash reserves.